MedPath

Dextromethorphan

Generic Name
Dextromethorphan
Brand Names
Auvelity, Benylin DM, Bromfed DM, Broncotron, Cepacol Sore Throat Plus Cough, Cheracol D, Children's Nyquil Cold and Cough, Chloraseptic Sore Throat + Cough, Coricidin Hbp Chest Congestion, Coricidin Hbp Cough and Cold, Creomulsion, DM, Dayquil Cough, Delsym, Delsym Cough Plus Chest Congestion DM, Delsym Cough Plus Soothing Action, Delsym Cough Relief Plus Soothing Action, Despec Reformulated Jun 2008, Diabetic Tussin DM, Dimetapp Long Acting Cough Plus Cold, Diphen, G-zyncof, Mucinex Children's Cough, Mucinex Cough, Mucinex DM, Nuedexta, Nyquil Cough, Pediacare Children's Cough and Congestion, Promethazine DM, Robafen Cough, Robafen DM, Robitussin 12 Hour Cough Relief, Robitussin Cough & Congestion, Robitussin Maximum Strength Cough Plus Chest Congestion DM, Robitussin Nighttime Cough DM, Robitussin Pediatric Cough & Cold LA, Robitussin Pediatric Cough Suppressant, Safetussin DM, Safetussin PM, Scot-tussin DM, Scot-tussin Diabetic CF, Scot-tussin Sugar Free DM, Sudafed PE Children's Cold & Cough, Triaminic Day Time Cold & Cough, Tusnel Diabetic
Drug Type
Small Molecule
Chemical Formula
C18H25NO
CAS Number
125-71-3
Unique Ingredient Identifier
7355X3ROTS
Background

Dextromethorphan is a levorphanol derivative and codeine analog commonly used as a cough suppressant and also a drug of abuse. Although similar in structure to other opioids, it has minimal interaction with opioid receptors.

Dextromethorphan was granted FDA approval before 3 December 1957.

Indication

Dextromethorphan is indicated in combination with brompheniramine and pseudoephedrine in the treatment of coughs and upper respiratory symptoms associated with allergies or the common cold. Dextromethorphan is also used in combination with guaifenesin as an over-the-counter product to relieve a cough. Dextromethorphan in combination with quinidine is indicated in the treatment of pseudobulbar affect.

Associated Conditions
Allergic cough, Common Cold, Cough, Cough caused by Common Cold, Coughing caused by Allergies, Coughing caused by Bronchitis, Coughing caused by Flu caused by Influenza, Fever, Flu caused by Influenza, Headache, Irritative cough, Itching of the nose, Itching of the throat, Major Depressive Disorder (MDD), Nasal Congestion, Pseudobulbar Affect (PBA), Rhinorrhoea, Sneezing, Cold or flu syndrome, Upper respiratory symptoms, Watery itchy eyes
Associated Therapies
Airway secretion clearance therapy, Bronchodilation, Oropharyngeal antisepsis

Dextromethorphan to Treat Patients With Voice Spasms

Phase 1
Completed
Conditions
Voice Disorders
First Posted Date
2003-03-05
Last Posted Date
2017-07-02
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Target Recruit Count
65
Registration Number
NCT00055549
Locations
🇺🇸

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Treatment for Chronic Pain in Patients With Advanced Cancer

Phase 3
Completed
Conditions
Leukemia
Lymphoma
Myelodysplastic Syndromes
Precancerous/Nonmalignant Condition
Unspecified Adult Solid Tumor, Protocol Specific
Pain
Small Intestine Cancer
Chronic Myeloproliferative Disorders
Multiple Myeloma and Plasma Cell Neoplasm
First Posted Date
2003-01-27
Last Posted Date
2020-04-03
Lead Sponsor
NCIC Clinical Trials Group
Target Recruit Count
87
Registration Number
NCT00003687
Locations
🇨🇦

McGill University, Montreal, Quebec, Canada

🇨🇦

Newfoundland Cancer Treatment and Research Foundation, St. Johns, Newfoundland and Labrador, Canada

🇨🇦

Princess Margaret Hospital, Toronto, Ontario, Canada

and more 1 locations

Dextromethorphan Versus Placebo for Neuropathic Pain

Phase 2
Completed
Conditions
Herpes Zoster
Neuralgia
Diabetic Neuropathies
First Posted Date
2002-12-10
Last Posted Date
2008-03-04
Lead Sponsor
National Institute of Dental and Craniofacial Research (NIDCR)
Target Recruit Count
129
Registration Number
NCT00001344
Locations
🇺🇸

National Institute of Dental And Craniofacial Research (NIDCR), Bethesda, Maryland, United States

Dextromethorphan for the Treatment of Parkinson's Disease and Similar Conditions of the Nervous System

Phase 2
Completed
Conditions
Neurodegenerative Disease
Parkinson's Disease
First Posted Date
2002-12-10
Last Posted Date
2006-07-13
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Target Recruit Count
42
Registration Number
NCT00001365
Locations
🇺🇸

National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, Maryland, United States

Research Study in Patients With Persistent Macular Edema

Phase 2
Completed
Conditions
Diabetes
Macular Edema
Diabetic Retinopathy
Retinal Disease
Uveitis, Posterior
First Posted Date
2002-05-07
Last Posted Date
2011-05-30
Lead Sponsor
Allergan
Target Recruit Count
315
Registration Number
NCT00035906
Locations
🇺🇸

Oculex Pharmaceuticals, Sunnyvale, California, United States

Study of the Pathogenesis of Rett Syndrome

Not Applicable
Completed
Conditions
Rett Syndrome
First Posted Date
2000-02-25
Last Posted Date
2005-06-24
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Target Recruit Count
120
Registration Number
NCT00004807

Studies of Dextromethorphan and Topiramate to Treat Oral and Facial Pain

Phase 2
Completed
Conditions
Facial Neuralgia
Trigeminal Neuralgia
Pain
First Posted Date
1999-11-04
Last Posted Date
2008-03-04
Lead Sponsor
National Institute of Dental and Craniofacial Research (NIDCR)
Target Recruit Count
100
Registration Number
NCT00001725
Locations
🇺🇸

National Institute of Dental And Craniofacial Research (NIDCR), Bethesda, Maryland, United States

Effects of Dextromethorphan on Opioid Tolerance in Methadone Patients - 1

Phase 2
Completed
Conditions
Substance-Related Disorders
Opioid-Related Disorders
First Posted Date
1999-09-21
Last Posted Date
2017-01-12
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Registration Number
NCT00000352
Locations
🇺🇸

University of Pennsylvania, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath